Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELBASVIR vs ELIGLUSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELBASVIR vs ELIGLUSTAT: Safety Overview

Metric ELBASVIR ELIGLUSTAT
Total FAERS Reports 367 1,368
Deaths Reported 58 18
Death Rate 15.8% 1.3%
Hospitalizations 175 173
Average Patient Age 64.1 yrs 48.6 yrs
% Female Patients 73.9% 57.1%
FDA Approval Date N/A Aug 17, 2022
Manufacturer Merck Sharp & Dohme LLC Genzyme Corporation
Route ORAL ORAL
Marketing Status N/A Prescription